{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:32:01Z","timestamp":1793035921692,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2014HL011"],"award-info":[{"award-number":["ZR2014HL011"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.biopha.2019.109480","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T12:01:16Z","timestamp":1569499276000},"page":"109480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system"],"prefix":"10.1016","volume":"120","author":[{"given":"Jing","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2019.109480_bib0005","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2019.109480_bib0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12013-015-0553-4","article-title":"Myocardial infarction: symptoms and treatments","volume":"72","author":"Lu","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.biopha.2019.109480_bib0015","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/labinvest.2017.100","article-title":"Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects","volume":"97","author":"Higuchi","year":"2017","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2019.109480_bib0020","first-page":"609","article-title":"Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury via eNOS-dependent mechanism","volume":"113","author":"Valle Raleigh","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2019.109480_bib0025","doi-asserted-by":"crossref","first-page":"25613","DOI":"10.1038\/srep25613","article-title":"Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury","volume":"6","author":"Lundy","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2019.109480_bib0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10557-015-6606-5","article-title":"Adenosine as an adjunct therapy in ST elevation myocardial infarction patients: Myth or Truth?","volume":"29","author":"Kassimis","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2019.109480_bib0035","first-page":"409","article-title":"Increased cardiac distribution of mono-PEGylated radix ophiopogonis polysaccharide in both myocardial infarction and ischemia\/reperfusion rats","volume":"10","author":"Yao","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2019.109480_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2003.10.008","article-title":"Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits","volume":"94","author":"Lukyanov","year":"2004","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biopha.2019.109480_bib0045","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/nnm.16.6","article-title":"Nanoparticle drug delivery systems and their use in cardiac tissue therapy","volume":"11","author":"Ho","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.biopha.2019.109480_bib0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of lipidoid nanoparticle carrying modRNA induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2019.109480_bib0055","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijpharm.2013.04.015","article-title":"Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia","volume":"454","author":"Sim\u00f3n-Yarza","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2019.109480_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4198790","article-title":"Magnetic nanoparticles for targeting and imaging of stem cells in myocardial infarction","volume":"2016","author":"Santoso","year":"2016","journal-title":"Stem Cells Int."},{"issue":"2","key":"10.1016\/j.biopha.2019.109480_bib0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/01913123.2017.1281367","article-title":"Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats","volume":"41","author":"Ahmed","year":"2017","journal-title":"Ultrastruct. Pathol."},{"issue":"Pt. A","key":"10.1016\/j.biopha.2019.109480_bib0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jconrel.2015.06.017","article-title":"Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction","volume":"220","author":"Dasa","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2019.109480_bib0075","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/mp500653y","article-title":"Delivery of lipid micelles into infarcted myocardium using a lipid-linked matrix metalloproteinase targeting peptide","volume":"12","author":"Nguyen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2019.109480_bib0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biopha.2017.02.029","article-title":"RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model","volume":"89","author":"Dong","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.biopha.2019.109480_bib0085","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1080\/03639045.2016.1190742","article-title":"In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles","volume":"42","author":"Liu","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2019.109480_bib0090","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/jf062796c","article-title":"Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with beta-carotene","volume":"55","author":"Han","year":"2007","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.biopha.2019.109480_bib0095","first-page":"4425","article-title":"Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-\u03b21 (TGF-\u03b21) pathway in myocardial infarction mice","volume":"8","author":"Tao","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.biopha.2019.109480_bib0100","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1039\/C0NR00781A","article-title":"Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents","volume":"3","author":"Sagnella","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2019.109480_bib0105","first-page":"3911","article-title":"Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy","volume":"10","author":"Qu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2019.109480_bib0110","doi-asserted-by":"crossref","first-page":"36435","DOI":"10.1038\/srep36435","article-title":"Water-soluble acacetin prodrug confers significant cardioprotection against ischemia\/reperfusion injury","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2019.109480_bib0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17425247.2016.1205583","article-title":"Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy","volume":"14","author":"Xiao","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2019.109480_bib0120","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3109\/10717544.2015.1055619","article-title":"Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109480_bib0125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2015.10.021","article-title":"Co-delivery of chemotherapeutics and proteins for synergistic therapy","volume":"98","author":"He","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2019.109480_bib0130","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/IJN.S120685","article-title":"Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers","volume":"12","author":"Ni","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.biopha.2019.109480_bib0135","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0735-1097(99)00456-8","article-title":"Combination therapy for acute myocardial infarction","volume":"34","author":"Keeley","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2019.109480_bib0140","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.2147\/IJN.S81451","article-title":"Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts","volume":"10","author":"Fang","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.biopha.2019.109480_bib0145","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/jps.23512","article-title":"Nanovesicles system for rapid-onset sublingual delivery containing sodium tanshinone IIA sulfonate: in vitro and in vivo evaluation","volume":"102","author":"Zhu","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"1-3","key":"10.1016\/j.biopha.2019.109480_bib0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2007.04.031","article-title":"Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis","volume":"568","author":"Fu","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109480_bib0155","first-page":"121","article-title":"Recent insights into the biological activities and drug delivery systems of tanshinones","volume":"11","author":"Cai","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"23","key":"10.1016\/j.biopha.2019.109480_bib0160","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jchromb.2010.06.001","article-title":"A validated stability-indicating HPLC method for the determination of PEGylated puerarin in aqueous solutions","volume":"878","author":"Liu","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.biopha.2019.109480_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.chemphyslip.2015.09.008","article-title":"Characterization, biorecognitive activity and stability of WGA grafted lipid nanostructures for the controlled delivery of Rifampicin","volume":"193","author":"Pooja","year":"2015","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biopha.2019.109480_bib0170","first-page":"3865","article-title":"Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles","volume":"9","author":"Omwoyo","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"31","key":"10.1016\/j.biopha.2019.109480_bib0175","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.jchromb.2010.10.011","article-title":"A HPLC-UV method for the determination of puerarin in rat plasma after intravenous administration of PEGylated puerarin conjugate","volume":"878","author":"Liu","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.biopha.2019.109480_bib0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biopha.2017.01.175","article-title":"Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: in vitro and in vivo evaluation","volume":"89","author":"Ma","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109480_bib0185","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2147\/IJN.S67147","article-title":"Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior","volume":"10","author":"Rehman","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2019.109480_bib0190","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.2147\/IJN.S165590","article-title":"Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.biopha.2019.109480_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22112040","article-title":"Solid lipid nanoparticles of albendazole for enhancing cellular uptake and cytotoxicity against U-87 MG glioma cell lines","volume":"22","author":"Marslin","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2019.109480_bib0200","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.2147\/IJN.S178650","article-title":"Effect of CCR2 inhibitor-loaded lipid micelles on inflammatory cell migration and cardiac function after myocardial infarction","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.biopha.2019.109480_bib0205","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1080\/10717544.2016.1223218","article-title":"Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats","volume":"23","author":"Zhang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109480_bib0210","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2147\/DDDT.S166749","article-title":"Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation","volume":"12","author":"Yu","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2019.109480_bib0215","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1208\/s12248-014-9638-z","article-title":"Prodrug applications for targeted cancer therapy","volume":"16","author":"Giang","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2019.109480_bib0220","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/DDDT.S166402","article-title":"Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib","volume":"12","author":"Duan","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2019.109480_bib0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.powtec.2010.02.035","article-title":"Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate","volume":"201","author":"Sanna","year":"2010","journal-title":"Powder Technol."},{"key":"10.1016\/j.biopha.2019.109480_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(00)00462-2","article-title":"Solid lipid nanoparticles (SLN\u2122) based on binary mixtures of liquid and solid lipids: a 1H-NMR study","volume":"205","author":"Jenning","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.biopha.2019.109480_bib0235","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/21\/215102","article-title":"Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery","volume":"20","author":"Yu","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biopha.2019.109480_bib0240","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.2147\/IJN.S141549","article-title":"Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles","volume":"12","author":"Shao","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.biopha.2019.109480_bib0245","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3109\/10717544.2016.1138339","article-title":"Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: in vitro evaluation, pharmacokinetic and biodistribution in rats","volume":"23","author":"Pawar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2019.109480_bib0250","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.biopha.2017.10.086","article-title":"\u03b1(v)\u03b2(3) integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia","volume":"96","author":"Qiu","year":"2017","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219332858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219332858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:44:53Z","timestamp":1760096693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219332858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":50,"alternative-id":["S0753332219332858"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109480","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109480"}}